Abnormal RET activation resulting from missense variants, gene fusions, or overexpression has been associated with various human diseases, including medullary thyroid carcinoma (MTC), Hirschsprung’s disease, and pheochromocytoma. Here, RET is linked to medullary thyroid gland carcinoma.